Discussion Solved

Remote collaboration tools that actually work for distributed research teams (61)

Back to Forum
Growing 85 pts 0 followers
St Aloysius (Deemed to be University) · Posted
Machine Learning & AI Renewable Energy

The honest answer to 'is a PhD worth it in India in 2025'

I will answer this question honestly because I see a lot of either uncritical enthusiasm or doom-and-gloom on this forum.

A PhD is worth it if:

  • You have a specific intellectual problem you are genuinely obsessed with
  • You want a career in research, academia, or high-end R&D at companies that value PhD credentials
  • You are comfortable with a 4–6 year period of relatively low pay and high uncertainty in exchange for intellectual freedom
  • You have a supervisor who is genuinely good at mentoring (this is the single biggest variable)

A PhD is probably not worth it if:

  • You want it for the credential rather than the research itself
  • You are going into fields (software engineering, finance, many business areas) where a PhD does not provide a salary premium
  • You are relying on it to 'figure out' what you want to do.that is what a master's degree is for

The Indian academic job market is brutal. If you want to be a professor at an IIT or IISC, you will likely need postdoctoral experience and a publication record that takes 8–10 years post-bachelor's to build.

But if research is genuinely what you want to do.it is absolutely worth it.

Sign in to interact

Sign in to join the discussion.

18 Replies

Oldest Top
0
Pooja Nambiar Growing 115 pts · Accepted answer

Could you clarify what you mean by results-blind review? I have heard of it but never understood how it works in practice. Wouldn't reviewers need to see results to evaluate whether the methodology is sound?

0
Kiran Yadav Growing 130 pts · Accepted answer

The IEEE TPAMI turnaround in my case was 7 months for the first review. Plan accordingly.

0
Bindiya Thomas Growing 65 pts · Accepted answer

For Zotero vs BibTeX management, I moved to Zotero + Better BibTeX 3 years ago and have not looked back.

My workflow:

  1. Zotero browser connector captures papers instantly from ArXiv, Google Scholar, ACM DL, IEEE Xplore
  2. Better BibTeX generates a clean .bib file that auto-updates whenever I add a paper
  3. Overleaf directly pulls from the .bib file via Dropbox sync

One tip: create a Zotero collection per paper/project. When you export the .bib, export only that collection to keep it clean.

0
Replying to Bindiya Thomas
Sunil Bhattacharya Active 390 pts · Accepted answer

This is really helpful context. One more question: for the ethics committee approval, does the institution where the data is collected or the institution where the analysis is performed need to be the primary ethics approver?

0
Replying to Bindiya Thomas
Anita Rao · Accepted answer

Overleaf + GitHub integration is underrated. You get version control and collaboration in one place.

0
Replying to Bindiya Thomas
Rajesh Kumar · Accepted answer

When you say 'multiple runs with confidence intervals', do you mean running the full training pipeline multiple times with different random seeds and reporting mean ± std? Or something more statistically rigorous?

0
Indira Balan · Accepted answer

CSIR-UGC NET preparation: past papers are the most important resource. Everything else is secondary.

0
Ravi Patel Starting 25 pts · Accepted answer

Flower (flwr) is the most actively maintained and research-friendly federated learning framework right now. My group has been using it for 18 months on a healthcare project with 4 hospital sites.

Strengths:

  • Clean simulation API that lets you test on a single machine before deploying
  • Good support for custom aggregation strategies (FedProx, FedNova)
  • Active Discord community with quick responses from the maintainers

For non-IID data specifically, look at the FedProx strategy.it handles heterogeneous data distributions much better than FedAvg.

0
Disha Malhotra Starting 8 pts · Accepted answer

Seconding the recommendation for Zotero. Game changer for managing references across multiple projects.

0
Rohan Desai Distinguished 950 pts · Accepted answer

This question comes up a lot. The answer really depends on your specific field and what your committee values.

0
Bindiya Thomas Growing 65 pts · Accepted answer

Respectfully, I think this framing misses the systemic dimension. Individual researchers cannot solve a collective action problem. If you submit to open-access journals and your colleague submits to Nature, your colleague gets the promotion. Until evaluation criteria change at the institutional level.which requires policy intervention.individual choices have minimal impact.

0
Hema Suresh Starting 20 pts · Accepted answer

The short answer: it depends heavily on the journal and field, but here is a general framework.

If your null result is well-powered and the hypothesis was reasonable: Absolutely publish it. Null results in well-designed studies are as valuable as positive results. Journals like PLOS ONE explicitly welcome them.

If your study is underpowered: Be transparent about it. Report effect sizes and confidence intervals, not just p-values. A small, underpowered study with honest reporting is still a contribution.

What kills papers is when limitations are obvious but the authors have not addressed them.

0
Replying to Hema Suresh
Jaya Lakshmanan Growing 50 pts · Accepted answer

This is very reassuring. I was worried the null result would kill the paper but your framing around transparency and effect sizes makes a lot of sense.

0
Replying to Hema Suresh
Disha Malhotra Starting 8 pts · Accepted answer

Thank you for the honest take. This is the kind of answer I was looking for.not the sanitized version.

0
Replying to Hema Suresh
Hema Suresh Starting 20 pts · Accepted answer

Much appreciated. I will restructure my proposal along these lines. The point about societal impact being substantive is something I would have gotten wrong.

0
Kiran Yadav Growing 130 pts · Accepted answer

FDR (Benjamini-Hochberg) is widely accepted and preferable to Bonferroni when you have many tests and limited power. The key is to be explicit about which correction you used and why.

On replication: No independent cohort is a genuine limitation but not a dealbreaker for rare disease research, where cohort availability is a known constraint. Many high-quality papers acknowledge this and still get published in good journals. Frame it as future work.

Power analysis: Yes, report it. Showing you are aware of the limitation is better than not mentioning it.

0
Replying to Kiran Yadav
Kavitha Subramanian Active 365 pts · Accepted answer

The Fulbright SoP is very different from a typical PhD SoP. It needs to focus on cultural exchange and diplomacy, not just research.

0
Replying to Kiran Yadav
Wajid Khan Growing 110 pts · Accepted answer

This is really helpful context. One more question: for the ethics committee approval, does the institution where the data is collected or the institution where the analysis is performed need to be the primary ethics approver?